Melanoma cell line-derived exosomal miR-424-5p: a key promoter of angiogenesis through LATS2 interaction
Oncology Research · 2025
DOI: 10.32604/or.2024.050878 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Research, 2025. Verfasst von Junwei DU und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bone and Soft Tissue Tumors and Melanoma, Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, 830000, China. Hauptthemen laut MEDLINE: MicroRNAs, Exosomes, Protein Serine-Threonine Kinases, Neovascularization, Pathologic. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Bone and Soft Tissue Tumors and Melanoma, Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, 830000, China.
Zitieren
APA
DU, J., Zhang, Q., Zhang, J., Maihemuti, M., He, H., & Jiang, R. (2025). Melanoma cell line-derived exosomal miR-424-5p: a key promoter of angiogenesis through LATS2 interaction. Oncology Research. https://doi.org/10.32604/or.2024.050878
Vancouver
DU J, Zhang Q, Zhang J, Maihemuti M, He H, Jiang R. Melanoma cell line-derived exosomal miR-424-5p: a key promoter of angiogenesis through LATS2 interaction. Oncology Research. 2025. doi:10.32604/or.2024.050878
BibTeX
@article{DU2025,
author = {DU, Junwei and Zhang, Qiang and Zhang, Jing and Maihemuti, Maierdanjiang and He, Haiyang and Jiang, Renbing},
title = {Melanoma cell line-derived exosomal miR-424-5p: a key promoter of angiogenesis through LATS2 interaction},
journal = {Oncology Research},
year = {2025},
doi = {10.32604/or.2024.050878}
}
EUVIMED